1. Biofluid GPNMB/osteoactivin as a potential biomarker of ageing: A cross-sectional study
- Author
-
Yuan-Yuan Liu, Jing Pang, Chi Zhang, Lv-Tao Zeng, Yao Wang, Shi-Bo Wang, Guo-Qing Fan, Li-Qun Zhang, Tao Shen, Xue-Fei Li, Chuan-Bao Li, Su-Yan Cao, Tie-Mei Zhang, Jian-Ping Cai, and Ju Cui
- Subjects
GPNMB ,Biomarker ,Aging ,Urine ,Serum ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: Glycoprotein non-metastatic melanoma B (GPNMB)/osteoactivin was first identified in the human melanoma cell lines. GPNMB plays a key role in the anti-inflammatory and antioxidative functions as well as osteoblast differentiation, cancer progression, and tissue regeneration. Recently, GPNMB was used as an anti-aging vaccine for mice. The present study aimed to investigate the potential of biofluid GPNMB as an aging biomarker in humans using serum and urine samples from an aging Chinese population. Methods: We analyzed RNA-sequencing data (GSE132040) from 17 murine organs across different ages to assess the gene expression of potential ageing biomarkers. Spearman's correlation coefficients were used to evaluate the relationship between gene expression and age. Meanwhile, a cross-sectional population study was conducted, which included 473 participants (aged 25–91 years), a representative subset of participants from the Peng Zu Study on Healthy Ageing in China (Peng Zu Cohort). Biofluid GPNMB levels were measured by ELISA. The associations of serum and urine GPNMB levels with various clinical and anthropometrical indices were assessed using ANOVA, Kruskal-Wallis H test, and univariate and multivariate linear regression analyses. Results: In mice, the Gpnmb mRNA expression levels showed a significant positive association with age in multiple organs in mice (P
- Published
- 2024
- Full Text
- View/download PDF